14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PEBK vs PROV: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Peoples Bancorp of North Carol (PEBK) is the stronger overall head-to-head candidate over Provident Financial Hldgs (PROV) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PEBK carries a Unified Composite Score of 53.2/100 (HOLD) at $42.26 (12.7x Forward P/E, 32.0% operating margin), whereas PROV carries 58.2/100 (HOLD) at $18.51 (17.8x Forward P/E, 24.3% operating margin).
Composite vs. Pillar Nuance: While PROV currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. PEBK 53.2/100 HOLD), PEBK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (32.0% vs. 24.3% operating margin) and revenue trajectory (+6.5% vs. -5.5% YoY).
Technical & Structure Timing Caution: PEBK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile PROV trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 65.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PEBK vs PROV. Trailing 12-month operating profitability (PEBK 32.0% vs PROV 24.3%) and valuation multiples (PEBK 12.7x vs PROV 17.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Banks - Regional value chain with $112.8M market capitalization and 24.3% operating margin.
OpEx & R&D Reinvestment75.7% of Rev ($30M)
90D Engineering Disclosures0 Published
Investor FAQ PEBK vs PROV Key Questions & Quantitative Answers
As of Nov 16, 2026, Peoples Bancorp of North Carol (PEBK) is the stronger overall head-to-head candidate over Provident Financial Hldgs (PROV) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PEBK carries a Unified Composite Score of 53.2/100 (HOLD) at $42.26 (12.7x Forward P/E, 32.0% operating margin), whereas PROV carries 58.2/100 (HOLD) at $18.51 (17.8x Forward P/E, 24.3% operating margin). Composite vs. Pillar Nuance: While PROV currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. PEBK 53.2/100 HOLD), PEBK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (32.0% vs. 24.3% operating margin) and revenue trajectory (+6.5% vs. -5.5% YoY). Technical & Structure Timing Caution: PEBK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile PROV trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 65.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PEBK leads the Growth & Scale pillar: PEBK posts +6.5% YoY revenue growth and +56.7% YoY earnings growth on $92M TTM revenue (100.0% gross margin, 32.0% operating margin), compared with PROV at -5.5% YoY revenue growth and +0.0% YoY earnings growth on $40M TTM revenue (100.0% gross margin, 24.3% operating margin). On trailing 12-month operating scale, PEBK generates $92M in USD-normalized revenue versus $40M for PROV. In operating R&D and SG&A reinvestment, PEBK deploys 68.0% of Rev ($62M) (0 90-day corporate R&D disclosures) versus 75.7% of Rev ($30M) (0 disclosures) for PROV.
PEBK screens cheaper on headline valuation multiples. PEBK trades at 12.7x Forward P/E, 10.8x Trailing P/E, N/M PEG, and 2.5x EV/Revenue (unreported cash flow margin), whereas PROV trades at 17.8x Forward P/E, 17.9x Trailing P/E, 4.00x PEG, and 2.8x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PEBK (14.3% ROE) versus PROV (5.2% ROE) capital efficiency.
In options market volatility and institutional positioning, PEBK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.29β · 29% Vol realized risk). By comparison, PROV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.06β · 6% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.